See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2016_Agile_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001261249, Agile Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 38,085,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,318,000 |
| 3 | remainder_Assets | 309,000 |
| 4 | LiabilitiesCurrent | 7,934,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,467,000 |
| 9 | ResearchAndDevelopmentExpense | 25,622,000 |
| 10 | remainder_Expenses | -3,785,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,031,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 50,712,000 |
| 1 | Liabilities | 7,934,000 |
| 2 | Expenses | 29,304,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 42,778,000 |
| 5 | NetIncome | -30,335,000 |
| 6 | ComprehensiveNetIncome | -30,335,000 |
| 7 | BaseVar | 44,490,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.15 |
| 9 | EconomicCapitalRatio | 3.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
